Antonio Gasbarrini
Overview
Explore the profile of Antonio Gasbarrini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
1047
Citations
20187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lenti M, Hammer H, Tacheci I, Burgos R, Schneider S, Foteini A, et al.
United European Gastroenterol J
. 2025 Mar;
PMID: 40088199
Malabsorption is a complex and multifaceted condition characterised by the defective passage of nutrients into the blood and lymphatic streams. Several congenital or acquired disorders may cause either selective or...
2.
Rondinella D, Raoul P, Valeriani E, Venturini I, Cintoni M, Severino A, et al.
Nutrients
. 2025 Mar;
17(5).
PMID: 40077728
Ultra-processed foods (UPFs) have become a widely consumed food category in modern diets. However, their impact on gut health is raising increasing concerns. This review investigates how UPFs impact the...
3.
Ribaudi E, Amato S, Becherucci G, Carillo S, Covello C, Mora V, et al.
Nutrients
. 2025 Mar;
17(5).
PMID: 40077704
This scoping review aims to map the existing literature on nutritional knowledge among people with IBD, identify gaps in current understanding, and provide guidance for future educational interventions. : Inflammatory...
4.
Puca P, Del Gaudio A, Iaccarino J, Blasi V, Coppola G, Laterza L, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075582
The advent of Janus kinase (JAK) inhibitors, including tofacitinib, filgotinib, and upadacitinib, has significantly widened the therapeutic options for patients with inflammatory bowel disease (IBD). These agents offer the advantage...
5.
Giorgio V, Venezia I, Pensabene L, Blasi E, Rigante D, Mariotti P, et al.
World J Clin Pediatr
. 2025 Mar;
14(1):97543.
PMID: 40059898
Background: Disorders of gut-brain interaction (DGBI) are common, but knowledge about their physiopathology is still poor, nor valid tools have been used to evaluate them in childhood. Aim: To develop...
6.
Privitera G, Monastero L, Melita E, Schiavoni E, Napolitano D, Barini A, et al.
Dig Liver Dis
. 2025 Mar;
PMID: 40023750
Background: Data on nonmedical switching from one anti-Tumor Necrosis Factor (TNF)-α biosimilar to another in inflammatory bowel disease (IBD) are relatively sparse. We aimed to study the effects of nonmedical...
7.
Stella L, Pallozzi M, Cerrito L, Santopaolo F, Tovoli F, Hollande C, et al.
Clin Gastroenterol Hepatol
. 2025 Feb;
PMID: 40020957
Background And Aims: Atezolizumab plus Bevacizumab (atezobeva) has changed the treatment landscape of advanced hepatocellular carcinoma (HCC), but its efficacy and safety in patients with impaired liver function are still...
8.
Sonnino R, Ciccarelli G, Moffa S, Soldovieri L, Giuseppe G, Brunetti M, et al.
iScience
. 2025 Feb;
28(2):111848.
PMID: 40008362
Metabolic syndrome (MetS) and mild cognitive impairment (MCI) are interconnected conditions sharing common pathological pathways, such as inflammation and oxidative stress, leading to the concept of "metabolic-cognitive syndrome." This highlights...
9.
Saviano A, Morabito Loprete M, Pignataro G, Piccioni A, Gasbarrini A, Franceschi F, et al.
Medicina (Kaunas)
. 2025 Feb;
61(2).
PMID: 40005462
Coronary artery disease (CAD) is one of the leading causes of death worldwide, significantly contributing to mortality in both developed and developing nations. CAD arises from a combination of risk...
10.
Celani L, Carbone L, Ceppa F, Piccioni A, Della Polla D, Chiuchiarelli M, et al.
Medicina (Kaunas)
. 2025 Feb;
61(2).
PMID: 40005357
: The management of HIV patients presenting with fever in the Emergency Department (ED) remains a challenging clinical scenario. Accurate risk stratification and prognostic indicators are crucial for timely intervention...